Big jump reported for drugs in clinical testing

A 52% increase in the number of drugs put into clinical testing was seen in the three years ending in 2005, according to a study by the Tufts Center for the Study of Drug Development. The increase is largely the result of new technologies that enable scientists to better evaluate a drug's potential for success and an increase in products licensed from other companies, according to the center's director.

View Full Article in:

Washington Post (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY